Catalyst Pharmaceuticals, Inc.【CPRX】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
4Q25
|
52,698
|
-5.8%
|
|
3Q25
|
52,783
|
+20.3%
|
|
2Q25
|
52,108
|
+27.7%
|
|
1Q25
|
56,737
|
+143.8%
|
|
4Q24
|
55,936
|
+60.5%
|
|
3Q24
|
43,884
|
-242.6%
|
|
2Q24
|
40,794
|
+8.0%
|
|
1Q24
|
23,275
|
-21.3%
|
|
4Q23
|
34,844
|
+36.8%
|
|
3Q23
|
-30,764
|
-235.2%
|
|
2Q23
|
37,762
|
+74.7%
|
|
1Q23
|
29,568
|
+123.3%
|
|
4Q22
|
25,471
|
+173.6%
|
|
3Q22
|
22,748
|
+120.2%
|
|
2Q22
|
21,619
|
+77.5%
|
|
1Q22
|
13,241
|
+72.8%
|
|
4Q21
|
9,309
|
-18.6%
|
|
3Q21
|
10,329
|
-76.2%
|
|
2Q21
|
12,181
|
+24.6%
|
|
1Q21
|
7,663
|
-26.5%
|
|
4Q20
|
11,437
|
+44.2%
|
|
3Q20
|
43,339
|
+218.0%
|
|
2Q20
|
9,779
|
-10.8%
|
|
1Q20
|
10,426
|
-1717.7%
|
|
4Q19
|
7,929
|
-154.7%
|
|
3Q19
|
13,630
|
-273.9%
|
|
2Q19
|
10,959
|
-283.7%
|
|
1Q19
|
-645
|
-88.7%
|
|
4Q18
|
-14,500
|
+169.1%
|
|
3Q18
|
-7,839
|
+87.6%
|
|
2Q18
|
-5,966
|
+53.7%
|
|
1Q18
|
-5,700
|
+14.8%
|
|
4Q17
|
-5,388
|
+29.4%
|
|
3Q17
|
-4,178
|
+5.7%
|
|
2Q17
|
-3,880
|
-15.1%
|
|
1Q17
|
-4,968
|
-7.8%
|
|
4Q16
|
-4,164
|
-28.4%
|
|
3Q16
|
-3,954
|
-11.1%
|
|
2Q16
|
-4,569
|
+0.2%
|
|
1Q16
|
-5,387
|
-0.4%
|
|
4Q15
|
-5,816
|
+66.6%
|
|
3Q15
|
-4,450
|
-11.2%
|
|
2Q15
|
-4,559
|
+42.5%
|
|
1Q15
|
-5,411
|
+42.0%
|
|
4Q14
|
-3,491
|
+157.6%
|
|
3Q14
|
-5,010
|
-15.3%
|
|
2Q14
|
-3,199
|
+1.7%
|
|
1Q14
|
-3,812
|
+118.5%
|
|
4Q13
|
-1,355
|
+1668.8%
|
|
3Q13
|
-5,913
|
+125.5%
|
|
2Q13
|
-3,144
|
+987.4%
|
|
1Q13
|
-1,745
|
+60.1%
|
|
4Q12
|
-77
|
-96.7%
|
|
3Q12
|
-2,622
|
+132.4%
|
|
2Q12
|
-290
|
-79.3%
|
|
1Q12
|
-1,090
|
-
|
|
4Q11
|
-2,352
|
-
|
|
3Q11
|
-1,128
|
-
|
|
2Q11
|
-1,395
|
-
|